Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

April 04, 2019 | Daily News

FDA will host a public hearing on May 31 to gather information about the health and safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived compounds, including cannabidiol (CBD), to help shape the agency’s regulatory oversight of cannabis, especially in food, the agency announced Tuesday (April 2).

April 04, 2019 | Daily News

Outgoing FDA chief Scott Gottlieb pinpointed complex generic and second-to-market novel drug development as two key areas in which he thinks the agency could have an effect in the drug pricing arena.

April 04, 2019 | Daily News

Departing FDA Commissioner Scott Gottlieb plans to return to his role at the American Enterprise Institute as a resident fellow and focus on the hot-button issue of drug pricing, he told the Washington Post.

April 03, 2019 | Daily News

The House Energy & Commerce Committee voted unanimously Wednesday (April 3) for six bills to cut drug prices after Democrats agreed to changes sought by Republicans to CREATES and pay-for-delay bills.

April 03, 2019 | Daily News

Rep. Mark Meadows (NC) is writing what he says is a comprehensive drug-pricing bill with fellow House Republicans that could expand rebate reforms to the commercial market, the Freedom Caucus chair told Inside Health Policy Wednesday (April 3).

April 03, 2019 | Daily News

Senate Republicans are buckling down on making prescription drug pricing a top health care priority after President Donald Trump upended their health care agenda last week by asking GOP senators to devise a plan to replace the Affordable Care Act.

April 03, 2019 | Daily News

Sen. Elizabeth Warren (D-MA) applauded FDA for funding research on durations of use for antibiotics in food animals.

April 02, 2019 | Daily News

The Senate on Tuesday (April 2) passed a bill to stop drug companies from avoiding Medicaid rebates by misclassifying brand drugs as generics, sending the first drug-pricing bill of this Congress to the president’s desk.

April 02, 2019 | Daily News

Ranking House Energy & Commerce Committee Republican Greg Walden (OR) said the two parties seem to have worked out differences on FDA-related drug pricing bills that the committee will mark up Wednesday (April 3).

April 02, 2019 | Daily News

Rep. Michael Burgess said maybe Medicare and Medicaid should cover insulin without cost-sharing because the cost to the health care system of diabetics rationing the drug is likely greater than the additional cost of covering it outright.

April 02, 2019 | Daily News

FDA will host a public hearing May 13 to gather input from stakeholders on what the agency could do to spur the first-ever availability of interchangeable prescription insulin products, coming as lawmakers criticize insulin makers for increasing prices to the point that some patients haven’t been able to afford the life-saving products.

April 02, 2019 | Daily News

Sen. Rick Scott said Tuesday (April 2) that he told President Donald Trump he is focused on lowering prescription drug prices, despite the president's request last week that he help lead an effort to replace the Affordable Care Act.

April 01, 2019 | Daily News

Hospitals are pleased that the Health Resources and Services Administration made the 340B ceiling price website available to 340B providers on Monday (April 1), and Maureen Testoni, president and CEO of 340B Health, said the group expects to get feedback from members over the next few months about the website and possible discrepancies between what hospitals pay for 340B drugs and the cap on what they should be charged.

April 01, 2019 | Daily News

CMS did not eliminate nonpreferred drug tiers or stop insurers from placing generics on brand drugs tiers.

April 01, 2019 | Daily News

CMS on Monday (April 1) finalized its call for Medicare Advantage and Part D plans to do more to reduce opioid dependence among beneficiaries and expand access to naloxone, the opioid overdose reversal drug, by reducing beneficiaries’ costs through new tiering policies, among other possible actions.

April 01, 2019 | Daily News

A Gilead subsidiary asked to negotiate an agreement with Louisiana to protect the company from potential losses under the Medicaid best price rule that could stem from participating in the state’s innovative subscription model to provide hepatitis C drugs to its Medicaid and corrections populations, according to documents obtained by Inside Health Policy.

April 01, 2019 | Daily News

Kite Pharma representatives pressed White House budget officials at a March 22 meeting to increase Medicare pay to hospitals for administering CAR-T, according to a White House log of the meeting, and they suggested pilot designs to test new pay arrangements for the expensive cancer treatments.

April 01, 2019 | Daily News

Senate Finance Chair Chuck Grassley (R-IA) on Wednesday (March 27) signaled he would back a bill extending the Trump administration’s proposal to shift rebates to the point of sale to the commercial market.

March 29, 2019 | Daily News

Outgoing FDA Commissioner Scott Gottlieb suggested Congress consider establishing incentives, including market exclusivity, to help drive development of safer pain medications.

March 29, 2019 | Daily News

Sen. Rick Scott (R-FL) on Friday (March 29) introduced an international reference pricing proposal for prescription drugs that is more aggressive than the Trump administration’s version that has rankled drug makers and split GOP lawmakers.

Pages